LXRX News and Press, Lexicon Pharmaceuticals Inc. From 01/09/21

Biotech Penny Stocks to Watch Friday, January 8th was a relatively good day for many penny stocks . After a week of volatility in the stock market, Friday represented a relatively calm day for investors. Now that the year is off to a decent start, there are a few catalysts that rema...

THE WOODLANDS, Texas, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, Lexicon’s president and chief executive officer, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday, January 14,...

Are Analysts Right About These Penny Stocks? In this article, we’re going to explore a few things about penny stocks , what they are, and how to do research. We’ll also talk a bit about 5 of these stocks that analysts rate a buy right now. So let’s dive in. ...

Lexicon Pharmaceuticals (LXRX) has initiated the dosing of the Phase 2 trial for LX9211 for the treatment of post-herpetic neuralgia, a disease with limited treatment options.With the involvement of 74 patients, the randomized, double-blind, placebo-controlled, clinical study will e...

THE WOODLANDS, Texas, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today the commencement of patient dosing in RELIEF-PHN 1, a Phase 2 randomized, placebo-controlled, multi-center clinical study of LX9211 for the treatment of post-herpeti...

Penny Stocks To Watch Before Next Week Penny stocks are well-known for being high risk. When it comes time to buy them, there are plenty of different emotions that come about. Though it’s important to keep emotion out of trading, sometimes you can’t help but let it slip. T...

4 Trending Penny Stocks To Watch For The End of December Penny stocks are often quite speculative due to their cheaper price. This is usually why new traders look to buy them as a first-time trade. While we wait for a vaccine and a stimulus bill to be passed in the U.S., many ...

Lexicon Pharmaceuticals (LXRX) +3% AH, entered a collaboration enabling the use by AC Bioscience LTD of preclinical and clinical data for LX2931 without granting any right or license under any of Lexicon's patent rights for the compound.Under agreement terms, Lexicon will receive an upfr...

Lexicon Pharmaceuticals (LXRX) collaborates to enable the use by AC Bioscience of preclinical and clinical data for LX2931 without granting any right or license under any of Lexicon’s patent rights for the compound. LX2931 is a small molecule sphingosine-1-phosphate (or S1P) ...

THE WOODLANDS, Texas, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it has entered a collaboration enabling the use by AC Bioscience LTD of preclinical and clinical data for LX2931 without granting any right or license under any...